Stirling Medical Innovations

Stirling Medical Innovations was a medical technology company based in Stirling, Scotland, that specialized in point-of-care diagnostic solutions. The company's flagship product, the Coag-Sense PT/INR Monitoring System, was designed to help clinicians and patients monitor prothrombin time for those on warfarin therapy. Unlike many competitors, Stirling's technology utilized a mechanical clot-detection system that directly measured the physical formation of a fibrin clot, providing high accuracy. In 2007, the company was acquired by Inverness Medical Innovations (now Alere, part of Abbott) to bolster its diagnostic testing portfolio. The technology remains a key component in the anticoagulation monitoring market due to its laboratory-grade precision in a portable format.